-
'Bionic breast' could restore sensation for cancer survivorsScientists are developing a new device that could help breast cancer patients who experience a loss of sensation after having a mastectomy.
By Emily Cooke Published
-
Healthy tissue may predict lung cancer return better than tumorsA new study suggests that the gene activity in healthy tissue surrounding tumors could better predict whether a patient's lung cancer might return after surgery.
By Emily Cooke Published
-
Millions more people need lung cancer screening, ACS saysNew guidelines from the American Cancer Society suggest millions more people should get yearly lung cancer screenings than were previously recommended to.
By Nicoletta Lanese Published
-
Cancer screening may not extend lives, new study suggests. But experts say it's flawed.A new analysis of screening tests for four types of cancer suggests that only one actually increases life span, on average. But what do scientists think?
By Emily Cooke Published
-
DNA's 'topography' influences where cancer-causing mutations appearThe topographical features of DNA in the body may dictate where and when cancer-causing mutations appear in its code.
By Rebecca Sohn Published
-
CRISPR used to 'reprogram' cancer cells into healthy muscle in the labIn a new study, stopping skeletal-muscle cancer cells from making a specific protein forced them to turn into healthy muscle cells.
By Emily Cooke Published
-
'Disappearing' Y chromosome in aging men may worsen bladder cancer, mouse study showsAs men get older, they can lose Y chromosomes in a portion of their cells. This could be helping certain cancers evade the immune system.
By Kiley Price Published
-
AI predicts 5-year breast cancer risk better than standard tools — but we aren't sure how it worksArtificial intelligence models can use breast imaging data to pinpoint those at highest risk of getting breast cancer in the next five years, better than a standard approach.
By Carissa Wong Published
-
Lung cancer pill drastically cuts risk of death after surgeryTaking the drug Tagrisso daily after surgery reduced non-small cell lung cancer patients' death risk by more than 50%.
By Jennifer Nalewicki Published
